HLTHCue Health Inc.

Nasdaq cuehealth.com


$ 0.14 $ 0.00 (-0.74 %)    

Wednesday, 01-May-2024 15:59:12 EDT
QQQ $ 422.58 $ -3.07 (-0.72 %)
DIA $ 378.81 $ 0.76 (0.2 %)
SPY $ 500.35 $ -1.63 (-0.32 %)
TLT $ 88.50 $ 0.65 (0.74 %)
GLD $ 213.80 $ 1.92 (0.91 %)
$ 0.135
$ 0.14
$ 0.00 x 0
$ 0.14 x 900
$ 0.14 - $ 0.14
$ 0.13 - $ 0.96
466,259
na
20.64M
$ 1.54
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-13-2024 12-31-2023 10-K
2 11-08-2023 09-30-2023 10-Q
3 08-09-2023 06-30-2023 10-Q
4 05-10-2023 03-31-2023 10-Q
5 03-16-2023 12-31-2022 10-K
6 11-09-2022 09-30-2022 10-Q
7 08-10-2022 06-30-2022 10-Q
8 05-11-2022 03-31-2022 10-Q
9 03-29-2022 12-31-2021 10-K
10 11-10-2021 09-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 cue-health-disclosed-it-has-been-undertaking-comprehensive-review-of-strategic-alternative-strategic-review-process-to-evaluate-options-including-potential-sale

-SEC Filing

 cue-health-reveals-strategic-actions-names-clint-sever-as-ceo-seeks-to-refine-and-strengthen-its-overarching-strategy-and-cost-structure

Clint Sever, co-founder and current Chief Product Officer, has been appointed CEO, effective immediately. Sever succeeds Ayub K...

 btig-downgrades-cue-health-to-neutral

BTIG analyst Mark Massaro downgrades Cue Health (NASDAQ:HLTH) from Buy to Neutral.

 cue-health-q4-earnings-insights
Cue Health: Q4 Earnings Insights
03/13/2024 20:10:24

 cue-health-q4-2023-adj-eps-032-beats-044-estimate-sales-18798m-beat-17681m-estimate

Cue Health (NASDAQ:HLTH) reported quarterly losses of $(0.32) per share which beat the analyst consensus estimate of $(0.44) by...

 earnings-scheduled-for-march-13-2024

Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share...

 cue-healths-earnings-outlook
Cue Health's Earnings Outlook
03/12/2024 16:01:56

 why-zscaler-shares-are-trading-lower-by-10-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of Zscaler, Inc. (NASDAQ: ZS) shares fell sharply during Friday’s session following second-quarter results.

 why-netapp-shares-are-trading-higher-by-around-17-here-are-20-stocks-moving-premarket

Shares of NetApp, Inc. (NASDAQ: NTAP) shares rose sharply in today’s pre-market trading after the company reported better-than...

 cue-health-has-received-a-decision-to-grant-european-patent-number-ep3191849-titled-systems-and-methods-for-detection-and-quantification-of-analytes

https://register.epo.org/application?number=EP15771337

 hlth-cue-health-says-estimates-will-record-aggregate-restructuring-charge-related-to-one-time-termination-benefits-in-range-of-about-32m-to-40m

-SEC Filing

 hlth-cue-health-says-plan-will-include-a-reduction-in-companys-employee-base-by-151-employees-on-jan-25-implemented-a-new-cost-reduction-plan-plan-constitutes-a-reduction-of-24-in-global-workforce

-SEC Filing

 cue-health-says-letter-shows-fda-determined-further-review-of-cos-eua-request-is-not-priority-therefore-declines-to-issue-eua-for-product-at-this-time-expects-payments-relating-to-the-crp-to-be-completed-by-the-end-of-q3-of-2024

-SEC Filing

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION